{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:15:10Z","timestamp":1788322510033,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genome Ed."],"abstract":"<jats:p>Lentiviral (LV) vectors have emerged as powerful tools for treating genetic and acquired human diseases. As clinical studies and commercial demands have progressed, there has been a growing need for large amounts of purified LV vectors. To help meet this demand, we developed CRISPR library screening methods to identify genetic perturbations in human embryonic kidney 293 (HEK293) cells and their derivatives that may increase LV vector titers. Briefly, LV vector-based Human CRISPR Activation and Knockout libraries (Calabrese and Brunello) were used to modify HEK293 and HEK293T cells. These cell populations were then expanded, and integrated LV vector genomes were rescued by transfection. LV vectors were harvested, and the process of sequential transduction and rescue-transfection was iterated. Through this workflow, guide RNAs (gRNAs) that target genes that may suppress or enhance LV vector production were enriched and identified with Next-Generation Sequencing (NGS). Though more work is needed to test genes identified in this screen, we expect that perturbations of genes we identified here, such as <jats:italic>TTLL12<\/jats:italic>, which is an inhibitor of antiviral innate immunity may be introduced and multiplexed to yield cell lines with improved LV vector productivity.<\/jats:p>","DOI":"10.3389\/fgeed.2023.1218328","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T16:46:07Z","timestamp":1689266767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["CRISPR library screening to develop HEK293-derived cell lines with improved lentiviral vector titers"],"prefix":"10.3389","volume":"5","author":[{"given":"Brian J.","family":"Iaffaldano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): A multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet lond. Engl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.omtm.2020.07.006","article-title":"Design and testing of vector-producing HEK293T cells bearing a genomic deletion of the SV40 T antigen coding region","volume":"18","author":"Bae","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cancers11020251","article-title":"Pan-cancer analyses reveal genomic features of FOXM1 overexpression in cancer","volume":"11","author":"Barger","year":"2019","journal-title":"Cancers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.omtn.2021.06.026","article-title":"Genome-wide activation screens to increase adeno-associated virus production","volume":"26","author":"Barnes","year":"2021","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.aac7557","article-title":"Gene essentiality and synthetic lethality in haploid human cells","volume":"350","author":"Blomen","year":"2015","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1152725","article-title":"Identification of host proteins required for HIV infection through a functional genomic screen","volume":"319","author":"Brass","year":"2008","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1093\/nar\/gkw707","article-title":"A programmable Cas9-serine recombinase fusion protein that operates on DNA sequences in mammalian cells","volume":"44","author":"Chaikind","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.gt.3300895","article-title":"Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system","volume":"6","author":"Chang","year":"1999","journal-title":"Gene Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1089\/104303403322495034","article-title":"Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a Duchenne myoblast cell line with long-term genotypic and phenotypic stability","volume":"14","author":"Cudr\u00e9-Mauroux","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molcel.2019.03.014","article-title":"Introducing a spectrum of long-range genomic deletions in human embryonic stem cells using Type I CRISPR-Cas","volume":"74","author":"Dolan","year":"2019","journal-title":"Mol. Cell."},{"key":"B13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/jlb.55.4.545","article-title":"HIV-1 envelope protein gp120 affects phenotype and function of monocytes in vitro","volume":"55","author":"D\u00fcrrbaum-Landmann","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.omtm.2019.11.021","article-title":"Lentiviral vector production titer is not limited in HEK293T by induced intracellular innate immunity","volume":"17","author":"Ferreira","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"D417","DOI":"10.1093\/nar\/gkn708","article-title":"Human immunodeficiency virus type 1, human protein interaction database at NCBI","volume":"37","author":"Fu","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1089\/hum.2010.143","article-title":"Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells","volume":"22","author":"Gama-Norton","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cell.2012.06.039","article-title":"TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes","volume":"150","author":"Gudjonsson","year":"2012","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.omto.2021.11.012","article-title":"Improved lentiviral vector titers from a multi-gene knockout packaging line","volume":"23","author":"Han","year":"2021","journal-title":"Mol. Ther. - Oncolytics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41434-018-0039-2","article-title":"Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization","volume":"25","author":"Hu","year":"2018","journal-title":"Gene Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"48702","DOI":"10.1371\/journal.pone.0048702","article-title":"Nucleolar protein trafficking in response to HIV-1 Tat: Rewiring the nucleolus","volume":"7","author":"Jarboui","year":"2012","journal-title":"PLOS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat. Protoc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.4049\/jimmunol.1601194","article-title":"TTLL12 inhibits the activation of cellular antiviral signaling through interaction with VISA\/MAVS","volume":"198","author":"Ju","year":"2017","journal-title":"J. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2008.07.032","article-title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication","volume":"135","author":"K\u00f6nig","year":"2008","journal-title":"Cell."},{"key":"B25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jviromet.2008.11.021","article-title":"Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection","volume":"157","author":"Kuroda","year":"2009","journal-title":"J. Virol. Methods"},{"key":"B26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Kutner","year":"2009","journal-title":"Nat. Protoc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1038\/ncomms5767","article-title":"Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations","volume":"5","author":"Lin","year":"2014","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1358\/dot.2017.53.11.2725754","article-title":"Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia","volume":"53","author":"Liu","year":"2017","journal-title":"Drugs Today Barc. Spain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.15252\/emmm.201708148","article-title":"Genome editing for scalable production of alloantigen\u2010free lentiviral vectors for in vivo gene therapy","volume":"9","author":"Milani","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: A comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell. Death Differ."},{"key":"B33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e39823","DOI":"10.7554\/eLife.39823","article-title":"A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV","volume":"7","author":"OhAinle","year":"2018","journal-title":"eLife"},{"key":"B36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/hgtb.2012.054","article-title":"Specific targeting of human interleukin (IL)-13 receptor \u03b12-positive cells with lentiviral vectors displaying IL-13","volume":"23","author":"Ou","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.omtm.2018.11.006","article-title":"CD46 null packaging cell line improves measles lentiviral vector production and gene delivery to hematopoietic stem and progenitor cells","volume":"13","author":"Ozog","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/v13020268","article-title":"Lentiviral vector bioprocessing","volume":"13","author":"Perry","year":"2021","journal-title":"Viruses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/QAD.0b013e328325a495","article-title":"HIV-Host interactions: A map of viral perturbation of the host system","volume":"23","author":"Pinney","year":"2009","journal-title":"AIDS Lond. Engl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1089\/aid.2008.0113","article-title":"Cataloguing the HIV type 1 human protein interaction network","volume":"24","author":"Ptak","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"B41","doi-asserted-by":"publisher","first-page":"15266","DOI":"10.1073\/pnas.93.26.15266","article-title":"Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles","volume":"93","author":"Reiser","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"15715","DOI":"10.1038\/s41598-021-95197-y","article-title":"Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients","volume":"11","author":"Rouchka","year":"2021","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1038\/s41467-018-07901-8","article-title":"Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities","volume":"9","author":"Sanson","year":"2018","journal-title":"Nat. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/cpt.1639","article-title":"Regulators\u2019 advice can make a difference: European medicines agency approval of zynteglo for beta thalassemia","volume":"107","author":"Schuessler\u2010Lenz","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/mtm.2016.80","article-title":"Marker of Self CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors","volume":"3","author":"Sosale","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"W345","DOI":"10.1093\/nar\/gkac247","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update","volume":"50","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B51","unstructured":"Carvykti fda"},{"key":"B52","unstructured":"FDA approves first cell-based gene therapy to treat adult and pediatric patients with beta-thalassemia who require regular blood transfusions FDA"},{"key":"B53","unstructured":"Skysona fda"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/bit.26382","article-title":"Generation of apoptosis-resistant HEK293 cells with CRISPR\/Cas mediated quadruple gene knockout for improved protein and virus production","volume":"114","author":"Zhang","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1128\/JVI.78.3.1219-1229.2004","article-title":"Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nbt.3715","article-title":"Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR\u2013Cas9 library","volume":"34","author":"Zhu","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1134\/S0026893319020171","article-title":"HIV restriction factors and their ambiguous role during infection","volume":"53","author":"Zotova","year":"2019","journal-title":"Mol. Biol."}],"container-title":["Frontiers in Genome Editing"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2023.1218328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T16:46:12Z","timestamp":1689266772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2023.1218328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":57,"alternative-id":["10.3389\/fgeed.2023.1218328"],"URL":"https:\/\/doi.org\/10.3389\/fgeed.2023.1218328","relation":{},"ISSN":["2673-3439"],"issn-type":[{"value":"2673-3439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"article-number":"1218328"}}